A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-18
Target enrollment:
Participant gender:
Summary
The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.